Autolus Therapeutics Plc (AUTL)
2.345
-0.06
(-2.70%)
USD |
NASDAQ |
Aug 24, 16:00
2.34
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Debt to Equity Ratio : 4.915 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.915 |
| March 31, 2026 | 3.392 |
| December 31, 2025 | 1.974 |
| September 30, 2025 | 1.225 |
| June 30, 2025 | 0.9097 |
| March 31, 2025 | 0.8384 |
| December 31, 2024 | 0.6956 |
| September 30, 2024 | 0.6314 |
| June 30, 2024 | 0.5469 |
| March 31, 2024 | 0.4808 |
| December 31, 2023 | 2.008 |
| September 30, 2023 | 0.2906 |
| June 30, 2023 | 0.2221 |
| March 31, 2023 | 0.1023 |
| December 31, 2022 | 0.5027 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.0939 |
| June 30, 2022 | 0.0802 |
| March 31, 2022 | 0.071 |
| December 31, 2021 | 0.067 |
| September 30, 2021 | 0.0891 |
| June 30, 2021 | 0.08 |
| March 31, 2021 | 0.0776 |
| December 31, 2020 | 0.2579 |
| September 30, 2020 | 0.2233 |
| June 30, 2020 | 0.109 |
| March 31, 2020 | 0.0927 |
| December 31, 2019 | 0.1029 |
| September 30, 2019 | 0.099 |
| June 30, 2019 | 0.092 |
| March 31, 2019 | 0.1292 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Bicycle Therapeutics Plc | 0.0298 |
| Biodexa Pharmaceuticals Plc | -- |
| argenx SE | -- |
| Mereo BioPharma Group Plc | 0.0359 |
| Evaxion AS | 0.7455 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 493.23M |
| Total Liabilities (Quarterly) | 418.39M |
| Shareholders Equity (Quarterly) | 74.84M |
| Current Ratio | 4.847 |
| Net Debt Paydown Yield | -2.66% |